Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the preliminary efficacy of nilotinib in pretreated patients with unresectable or metastatic gastrointestinal stromal tumors. Efficacy is defined as stable disease (SD), partial response (PR) or complete response (CR) during the first 4 months according to RECIST criteria.
Inclusion criteria
- gastrointestinal stromal tumors